IOVAIOVANCE BIOTHERAPEUTICS, INC.vs its industry peers
A metric-by-metric comparison of IOVANCE BIOTHERAPEUTICS, INC. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IOVA본 종목 | $1.9B#1 | — | 2.7x#2 | 7.3x#2 | 60.6%#4 | -5.1%#3 | -153.1%#3 | -54.2%#2 | — | — | 60.6%#1 | — |
| GLUE | $1.3B#2 | — | 2.5x#1 | 10.5x#3 | 63.5%#3 | 46.9%#2 | -43.8%#2 | -7.4%#1 | — | — | — | — |
| NVAX | $1.2B#3 | — | — | 1.1x#1 | 64.7%#2 | 334.8%#1 | 40.3%#1 | — | — | — | — | — |
| INBX | $1.2B#4 | — | — | 932.9x#4 | 550.0%#1 | -108.3%#4 | -10386.5%#4 | — | — | — | — | — |
| VOR | $1.2B#5 | — | — | — | — | -495.3%#5 | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-08-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice